Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Shanghai Pharmaceuticals, through its biotherapeutic R&D units, maintains an extensive clinical and registration pipeline—particularly in oncology, autoimmune, and chronic diseases—covering innovative biologics, biosimilars, and novel small molecules; a number of assets are in phase 2/3 and several brand/generic products are approved and commercialized domestically and internationally[2][3].
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Shanghai Pharmaceutical Group Biological Therapy Technology.